KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) Equity Average (2016 - 2025)

Chemed (CHE) has 16 years of Equity Average data on record, last reported at $1.0 billion in Q4 2025.

  • For Q4 2025, Equity Average fell 12.68% year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $1.0 billion, down 12.68%, while the annual FY2025 figure was $1.0 billion, 5.77% down from the prior year.
  • Equity Average reached $1.0 billion in Q4 2025 per CHE's latest filing, down from $1.1 billion in the prior quarter.
  • Across five years, Equity Average topped out at $1.2 billion in Q3 2024 and bottomed at $645.0 million in Q1 2022.
  • Average Equity Average over 5 years is $958.8 million, with a median of $950.9 million recorded in 2023.
  • Peak YoY movement for Equity Average: decreased 29.51% in 2022, then skyrocketed 40.17% in 2023.
  • A 5-year view of Equity Average shows it stood at $701.5 million in 2021, then rose by 8.35% to $760.1 million in 2022, then skyrocketed by 39.93% to $1.1 billion in 2023, then rose by 10.7% to $1.2 billion in 2024, then dropped by 12.68% to $1.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Average were $1.0 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.2 billion in Q2 2025.